Osteoarthritis (OA) is the most diagnosed joint disease in both the human and the animal world. OA is a disease of aging, an extremely painful, progressive degenerative process of synovial joints. It is a multifactorial disease with genetic predisposition along with the personal lifestyle of every dog with a fatty diet and sedentary lifestyles.  

In North America, prevalence values range from 20% in dogs older than one year up to 80% in dogs older than eight years, based on radiography and clinical setting. Proper and timely diagnosis may have missed the real numbers. NSAIDS drugs are mostly used for therapy but recently there are some selective COX-2 inhibitors (Coxibs) approved for canine OA. Although they relieve the pain temporarily, they have their own side effects. A number of glucosamine /MSM supplements are available for dogs but several reports/studies showed the ineffectiveness of those in the human or in dog population. 

Anitrex® is a unique dog chew, proprietary blend that has four unique anti-inflammatory herbs. Anitrex® is clinically tested in a placebo-controlled trial. 

• For use in dogs only
• For bone and joint health
• Helps flexibility
• Promotes mobility
• Proprietary formulation
• Enhances healthy joint function
• Supports an active life
• Combination of 4 plant extracts to US patent specifications
• In Animal Health – currently used for OA in some pets with excellent safety and efficacy
• Manufactured in the US